Drug Abuse Testing Market To Reach US$ 9.8 Billion By 2028

IMARC Group, a leading market research company, has recently releases report titled “Drug Abuse Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the global drug abuse testing market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights

How big is the drug abuse testing market?

The global drug abuse testing market size reached US$ 6.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.8 Billion by 2028, exhibiting a growth rate (CAGR) of 6.9% during 2023-2028.

What is drug abuse testing?

Drug abuse refers to the deliberate consumption of illegal substances or the overconsumption of prescribed psychoactive and over-the-counter (OTC) medications. It can affect the mind and body and cause several disorders, including addiction. As a result, drug abuse is diagnosed by using numerous testing methods to treat related problems effectively. Drug abuse testing also aids in managing the mental status of a patient, handling seizure cases in the emergency room, identifying children and newborns at risk of exposure to illicit drugs, etc. It also finds extensive applications in workplaces where job applicants can be tested for drug usage before being hired.

Request for a free sample copy of this report: https://www.imarcgroup.com/drug-abuse-testing-market/requestsample

What are the growth prospects and trends in the drug abuse testing industry?

The rising drug production and consumption represents the primary factor driving the market growth. Additionally, the increasing number of individuals consuming alcohol and illicit drugs, such as marijuana, cocaine, and opioids, is positively influencing market growth. Moreover, drugs such as opiates, cannabinoids, cocaine, alcohol, diazepam, lysergic acid diethylamide (LSD), barbiturates, amphetamines, and ketamine are abused for their psychological impact, non-therapeutic and medicinal uses, along with other purposes, such as weight loss and enhancing athletic performance. In line with this, the rising drug dependence and substance use disorder has catalyzed market growth. Besides this, drug abuse can pose severe risks to health and safety and lower the morale and productivity of individuals. As a result, the escalating demand for drug abuse testing for employee and job applicant screening to ensure a safe workplace is propelling the market growth.

Apart from this, the rising demand for urine drug testing due to rapid expansion in pain management and opioid dependency clinics is another major growth-inducing factor. Furthermore, several key players are launching automated testing and analysis for drug abuse and at-home use kits for instant drug abuse tests, thereby contributing to the market growth. Other factors, including increasing mortality due to drugs, the emerging e-commerce industry, technological advancements in drug screening or testing devices, and stringent government policies mandating drug screening, are also creating a favorable market outlook. Looking forward, IMARC Group expects the market value to reach US$ 9.8 Billion by 2028, expanding at a CAGR of 6.9% during 2023-2028.

What is included in market segmentation?

The report has segmented the market into the following categories:

Breakup by Product:

• Analyzers
• Immunoassays Analyzers
• Chromatographic Devices
• Breath Analyzers
• Rapid Testing Devices
• Urine Testing Devices
• Oral Fluid Testing Devices
• Consumables
• Laboratory Services

Breakup by Sample:

• Urine
• Oral Fluid (Saliva)
• Hair
• Breath
• Others

Breakup by End User:

• Hospitals
• Diagnostic Laboratories
• Forensic Laboratories
• Workplaces
• Others

Breakup by Region:

• North America (U.S. & Canada)
• Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
• Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
• Latin America (Brazil, Mexico)
• Middle East & Africa

Who are the key players operating in the industry?

The report covers the major market players including:

• Abbott Laboratories
• Bio-Rad Laboratories Inc.
• Danaher Corporation
• Drägerwerk AG & Co. KGaA
• Hoffmann-La Roche AG
• Laboratory Corporation of America Holdings
• Omega Laboratories Inc.
• Quest Diagnostics Incorporated
• Siemens AG
• Thermo Fisher Scientific Inc.
• United States Drug Testing Laboratories Inc.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=4388&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.